Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding

Journal of Immunology

Volumn 169, Issue 8, 2002, Pages 4098-4102

  Salih, Helmut R ^a   Rammensee, Hans Georg ^a   Steinle, Alexander ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; METALLOPROTEINASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DISEASE MARKER; EPITHELIUM; EPITHELIUM TUMOR; GASTROINTESTINAL TUMOR; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; T LYMPHOCYTE ACTIVATION; TUMOR CELL; TUMOR IMMUNITY;

EID: 0037108517     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.8.4098     Document Type: Article

References (23)

1. Lanier, L. L. 2000. On guard-activating NK cell receptors. Nat. Immunol. 2:23.
2. Moretta, L., R. Biassoni. C. Bottino, M. C. Mingari, and A. Moretta. 2000. Human NK-cell receptors. Immunol. Today 21:420.
3. Vivier, E., E. Tomasello, and P. Paul. 2002. Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? Curr. Opin. Immunol. 14:306.
4. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Philips, L. L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stressinducible MICA. Science 285:727.
5. Li, P., D. Morris, B. E. Willcox, A. Steinle, T. Spies, and R. K. Strong. 2001. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat. Immunol. 2:443.
6. Groh, V., S. Bahram, S. Bauer, A. Herman, M. Beauchamp, and T. Spies. 1996. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA 93:12445.
7. Groh, V., R. Rhinehart, H. Secrist, S. Bauer, K. H. Grabstein, and T. Spies. 1999. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA 96:6879.
8. Groh, V., A. Steinle, S. Bauer, and T. Spies. 1998. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science 279:1737.
9. Groh, V., R. Rhinehart, J. Randolph-Habecker, M. S. Topp, S. R. Riddell, and T. Spies. 2001. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2:255.
10. Fodil, N., L. Laloux, V. Wanner, P. Pellet, G. Hauptmann, N. Mizuki, H. Inoko, T. Spies, I. Theodorou, and S. Bahram. 1996. Allelic repertoire of the human MHC class I MICA gene. Immunogenetics 44:351.
11. Steinte, A., P. Li, D. L. Morris, V. Groh, L. L. Lanier, R. K. Strong, and T. Spies. 2001. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 53:279.
12. Cosman, D., J. Müllberg, C. L. Sutherland, W. Chin, R. Armitage, W. Fanslow, M. Kubin and N. J. Chalupny. 2001. ULBPs, novel MHC class I-related molecules bind to CMV glycoprotein ULI6 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14:123.
13. Cerwenka, A., A. B. H. Bakker, T. McClanahan, J. Wagner, J. Wu, J. H. Philips, and L. L. Lanier. 2000. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12:721.
14. Diefenbach, A., A. M. Jamieson, S. D. Liu, N. Shastri, and D. H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:119.
15. Girardi, M., D. E. Oppenheim, C. R. Steele, J. M. Lewis, E. Glusac, R. Filler, P. Hobby, B. Sutton, R. E. Tigelaar, and A. C. Hayday. 2001. Regulation of cutaneous malignancy by γδ T cells. Science 294:605.
16. Diefenbach, A., E. R. Jensen, A. M. Jamieson, and D. H. Raulet. 2001. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413:165.
17. Lanier, L. L. 2001. A renaissance for the tumor immunosurveillance hypothesis. Nat. Med. 11:1178.
18. McGeehan, G. M., J. D. Becherer. R. C. Bast, Jr., C. M. Boyer, B. Champion, K. M. Connolly, J. G. Conway, P. Furdon, S. Karp, S. Kidao, et al. 1994. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature 370:558.
19. Schneider, P., N. Holler, J. L. Bodmer, M. Hahne, K. Frei, A. Fontana, and J. Tschopp. 1998. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of the proapoptotic activity and loss of liver activity. J. Exp. Med. 187:1205,
20. Tanaka, M., T. Itai, M. Adachi, and S. Nagata. 1998. Downregulation of Fas ligand by shedding. Nat. Med. 4:31.
21. Bailey, S., B. Bolognese, D. R. Buckle, A. Faller, S. Jackson, P. Louis-Flamberg, M. McCord, R. J. Mayer, L. A. Marshall, and D. G. Smith. 1998. Hydroxamatebased inhibitors of low affinity IgE receptor (CD23) processing. Bioorg. Med. Chem. Lett. 8:23.
22. Cerwenka, H., J. L. Baron, and L. L. Lanier. 2001. Ectopic expression of retinoic acid early inducible-1 gene (RAE-I) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 98:11521.
23. Vihinen, P., and V.-M. Kähäri. 2002. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int. J. Cancer 99:157.